ABCG2 and cancer: Recognizing that chemoresistance represents a major obstacle in cancer treatment, we conducted drug resistance profiling for quercetin and lupeol by correlating their values to classical drug resistance genes, including ABC transporters, oncogenes, tumor suppressors, and other mechanisms.